These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 12048689)

  • 1. [Molecular genetics and clinical application of Rh blood group system].
    Zhang J; Hou Y; Tang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):246-9. PubMed ID: 12048689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of RH and its clinical application.
    Flegel WA
    Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rh proteins: key structural and functional components of the red cell membrane.
    Van Kim CL; Colin Y; Cartron JP
    Blood Rev; 2006 Mar; 20(2):93-110. PubMed ID: 15961204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw.
    Reiner AP; Teramura G; Aramaki KM
    Am J Perinatol; 1999; 16(6):277-81. PubMed ID: 10586980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rh system genotyping in amniotic fluid].
    Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Martino W; Racca A
    Medicina (B Aires); 2001; 61(1):76-8. PubMed ID: 11265629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK; Burton G; Leigh D; Marshall JT; Persson JW; Morris JM
    Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal blood group genotyping: present and future.
    Daniels G; Finning K; Martin P; Summers J
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of ABO-haemolytic disease of the newborn.
    Haque KM; Rahman M
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhd and C/cE/e genotyping in Slovenian population.
    Rupreht RR; Faas BH; Bojanic V; van Wijk PA; Glonar L; Bricl I; Rozman P; Curin Serbec V
    Pflugers Arch; 2000; 439(3 Suppl):R58-9. PubMed ID: 10653143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
    Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
    Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal determination of fetal RhD (rhesus positive) type by an amplification of DNA.
    Kvasnicka J; Rypácková B; Calda P; Hájek Z
    Sb Lek; 1998; 99(1):13-20. PubMed ID: 9748794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.